IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

BackgroundMutation-derived neoantigens are critical targets for tumor rejection in cancer immunotherapy, and better tools for neoepitope identification and prediction are needed to improve neoepitope targeting strategies. Computational tools have enabled the identification of patient-specific neoant...

Full description

Bibliographic Details
Main Authors:	Annie Borch, Ibel Carri, Birkir Reynisson, Heli M. Garcia Alvarez, Kamilla K. Munk, Alessandro Montemurro, Nikolaj Pagh Kristensen, Siri A. Tvingsholm, Jeppe Sejerø Holm, Christina Heeke, Keith Henry Moss, Ulla Kring Hansen, Anna-Lisa Schaap-Johansen, Frederik Otzen Bagger, Vinicius Araujo Barbosa de Lima, Kristoffer S. Rohrberg, Samuel A. Funt, Marco Donia, Inge Marie Svane, Ulrik Lassen, Carolina Barra, Morten Nielsen, Sine Reker Hadrup
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Immunology
Subjects:	neoantigen neoepitope prediction machine learning immunotherapy immunoinformatics
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1360281/full

Similar Items

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2017-11-01)

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2018-05-01)

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
by: Annie Borch, et al.
Published: (2023-03-01)

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations
by: Ulla Kring Hansen, et al.
Published: (2020-03-01)

Comparative performance analysis of neoepitope prediction algorithms in head and neck cancer
by: Leila Y. Chihab, et al.
Published: (2025-03-01)

T Cell Epitope Prediction and Its Application to Immunotherapy
by: Anna-Lisa Schaap-Johansen, et al.
Published: (2021-09-01)

Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
by: Mary A. Wood, et al.
Published: (2020-03-01)

Beyond MHC binding: immunogenicity prediction tools to refine neoantigen selection in cancer patients
by: Ibel Carri, et al.
Published: (2023-04-01)

Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
by: Eric de Sousa, et al.
Published: (2021-07-01)

SIGANEO: Similarity network with GAN enhancement for immunogenic neoepitope prediction
by: Yilin Ye, et al.
Published: (2023-01-01)

Predicting T cell recognition of MHC class I restricted neoepitopes
by: Zeynep Koşaloğlu-Yalçın, et al.
Published: (2018-11-01)

Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
by: Huahui Yu, et al.
Published: (2021-11-01)

Circular RNAs as a potential source of neoepitopes in cancer
by: Jiaqi Xia, et al.
Published: (2023-04-01)

The neoepitope landscape of breast cancer: implications for immunotherapy
by: Pooja Narang, et al.
Published: (2019-03-01)

Neoepitope fragments as biomarkers for different phenotypes of intervertebral disc degeneration
by: Shangbin Cui, et al.
Published: (2022-09-01)

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
by: Teresa Rodriguez-Calvo, et al.
Published: (2021-04-01)

Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
by: Shinji Morisaki, et al.
Published: (2023-10-01)

The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
by: Els M. E. Verdegaal, et al.
Published: (2017-09-01)

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
by: Jiaqi Xia, et al.
Published: (2021-04-01)

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display
by: Stina L. Wickström, et al.
Published: (2019-12-01)

Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature
by: Marta Riba, et al.
Published: (2021-06-01)

Tumor Neoepitope-Based Vaccines: A Scoping Review on Current Predictive Computational Strategies
by: Luiz Gustavo do Nascimento Rocha, et al.
Published: (2024-07-01)

Clinical implications of neoepitope landscapes for adult and pediatric cancers
by: Yang-Yang Feng, et al.
Published: (2017-08-01)

Cartilage Collagen Neoepitope C2C Expression in the Articular Cartilage and Its Relation to Joint Tissue Damage in Patients with Knee Osteoarthritis
by: Taavi Torga, et al.
Published: (2024-05-01)

A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations
by: Jugmohit S. Toor, et al.
Published: (2018-01-01)

Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation
by: Lasse Stach, et al.
Published: (2021-10-01)

Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement
by: Aarti Narang, et al.
Published: (2017-06-01)

Amide-containing neoepitopes: the key factor in the preparation of hapten-specific antibodies and a strategy to overcome
by: Xiangning Han, et al.
Published: (2023-06-01)

Cartilage collagen neoepitope C2C in urine as an integrative diagnostic marker for early knee osteoarthritis
by: Liisa Kuhi, et al.
Published: (2020-12-01)

A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo
by: Mathias Vormehr, et al.
Published: (2019-03-01)

Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
by: Nikolaj Pagh Kristensen, et al.
Published: (2022-01-01)

Risk Assessment of the Progression of Early Knee Osteoarthritis by Collagen Neoepitope C2C: A Longitudinal Study of an Estonian Middle-Aged Cohort
by: Liisa Kuhi, et al.
Published: (2021-07-01)

Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells
by: W Richter, et al.
Published: (2012-05-01)

Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report
by: Katja Sonntag, et al.
Published: (2018-02-01)

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
by: Apostolos Zaravinos, et al.
Published: (2019-08-01)

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
by: Vinicius Araujo B. de Lima, et al.
Published: (2021-03-01)

Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
by: Ruben Victor Huis in ‘t Veld, et al.
Published: (2021-09-01)

Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker
by: Vassiliadis Efstathios, et al.
Published: (2012-07-01)

Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation
by: Skjøt-Arkil Helene, et al.
Published: (2012-07-01)

DNA based neoepitope vaccination induces tumor control in syngeneic mouse models
by: Nadia Viborg, et al.
Published: (2023-05-01)